pyridostigmine bromide has been researched along with levetiracetam in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Aysal, F; Baybas, S; Kucukoglu, H; Ozturk, M; Selçuk, HH; Sozmen, V; Urer, NH | 1 |
2 other study(ies) available for pyridostigmine bromide and levetiracetam
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up.
Topics: Anticonvulsants; Cholinesterase Inhibitors; Electroencephalography; Follow-Up Studies; Levetiracetam; Magnetic Resonance Imaging; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Piracetam; Pyridostigmine Bromide; Seizures; Thymectomy; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2013 |